Clinical symptoms in the intestine and extraintestinal manifescation in inflammatory bowel disease in 108 Military Central Hospital

  • Đinh Thị Ngà Bệnh viện Trung ương Quân đội 108
  • Nguyễn Cảnh Bình Bệnh viện Trung ương Quân đội 108
  • Thái Doãn Kỳ Bệnh viện Trung ương Quân đội 108
  • Nguyễn Lâm Tùng Bệnh viện Trung ương Quân đội 108
  • Hoàng Kim Ngân Bệnh viện Trung ương Quân đội 108
  • Phạm Minh Ngọc Quang Bệnh viện Trung ương Quân đội 108
  • Dương Thị Tuyết Bệnh viện Trung ương Quân đội 108
  • Mai Thu Hoài Bệnh viện Trung ương Quân đội 108
  • Phạm Thị Châu Loan Bệnh viện Trung ương Quân đội 108
  • Lê Thị Thuận Bệnh viện Trung ương Quân đội 108
  • Bùi Thị Ánh Bệnh viện Trung ương Quân đội 108

Main Article Content

Keywords

Inflammatory bowel disease, ulcerative colitis

Abstract

Objective: To evaluate the clinical symptoms in the intestine and extraintestinal manifestation in inflammatory bowel disease. Subject and method: 87 inpatients treated from October 2020 to September 2022 at 108 Military Central Hospital. A descriptive, cross-sectional study. Result: The mean age of the study was 43.8; men accounted for 64.4%; Crohn's accounted for 51.7% and ulcerative colitis accounted for 48.3%. The main clinical symptoms of Crohn's disease were abdominal pain 88.9%; digestive disorders (66.7%). The main symptom of ulcerative colitis was bloody stools (88%). Crohn's related to surgery accounted for 18.4%; cause of perforation accounted for 37.5%. There were 24.1% of patients with extra-intestinal symptoms: Joints (61.9%); mucosal skin (28.6%). Conclusion: Inflammatory bowel disease includes 2 Crohn's disease and ulcerative colitis. These diseases present clinical symptoms in the intestine and extra-intestinal symptoms. Extraintestinal manifestations of Crohn's disease are more common than ulcerative colitis.

Article Details

References

1. Nguyễn Thị Thu Hiền và cộng sự (2020) Bệnh Crohn chẩn đoán và điều trị. Tạp chí khoa học tiêu hoá Việt Nam 2020- Tập IX- số 58.
2. WY Mak et al (2020) The epidemiology of IBD: East meets West. Journal of Gastroenterology and Hepatology 35: 380-389.
3. Lichtenstein et al (2018) ACG Clinical Guideline: Management of Crohn’s Disease in Adults. Am J Gastroenterol 113:481-517.
4. Siew et al (2013) Incidence and phenotype of Inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology Study. Gastroenteroly 145: 158-165.
5. Wei et al (2013) A nationwide population-based study of the inflammatory bowel diseases between 1998 and 2008 in Taiwan. BMC Gastroenterology 13: 166.
6. Abdulrahman M et al (2014) Clinical epidemiology and phenotypic characteristics of Crohn’s disease in the central region of Saudi Arabia. The Saudi Journal of Gastroenterology 20(3): 162-169.
7. Sandra M et al (2012) Association of age at diagnosis and ulcerative colitis phenotype. Dig Dis Sci 57(9).
8. Joseph D (2017) Crohn disease: Epidemiology, diagnosis, and management. 2017 Mayo Foundation for Medical Education and Research n Mayo Clin Proc: 1-16.
9. Satsangi J (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55: 749-753. doi: 10.1136/gut.2005.082909.
10. Javier P Gisbert et al (2008) Timing of surgery in Crohn’s disease: A key issue in the management. World J Gastroenterol 14(36): 5532-5539.
11. Jonathan S, Levine et al (2011) Extraintestinal Manifestations of Inflammatory Bowel Disease” Gastroenterology & Hepatology 7(4).
12. Istvan Fedor et al (2021) Temporal relationship of extraintestinal manifestations in inflammatory bowel disease. J. Clin. Med 10: 5984.